Description:NebuSelect™ Recombinant Human Histone H2A type 3(Cat#NBL-240516) is expressed in E.coli without tag.It contains Ser2-Lys130.

Species:Human

Expression System:E.coli

Molecular Weight: The protein has a predicted MW of 13.99 kDa. The protein migrates to 15-20 kDa based on Bis-Tris PAGE result.

Target Name:Histone H2A type 3

Target Information:The family of histone H2A proved that there are a lot of variants associated with cancer development. HIST3H2A is a promising biomarker for predicting prognosis of pancreatic cancer, and it could be a potential therapeutic target. HIST3H2A might regulate the progression of tumor immune in pancreatic cancer through modulating the JAK-STAT pathway. In addition, the role HIST3H2A in pancreatic cancer may be related to DCST1-AS1, HIST1H2B, SLC12A9-AS1.

Amino Acid Sequence: Ser2-Lys130

Purity:＞95%

Endotoxin:＜1EU/ug(LAL Method)